AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

6488.20

-12.55 (-0.19%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

6488.20

-12.55 (-0.19%)
15:51 Dec 20

Quality

72/100
High Financial Strength

Valuation

6/100
Expensive Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	813.56	805.6	1002.97	1295.53	1484.51
Operating Expenses +	678.09	719.42	837.85	1111.08	1329.42
Raw Material	292	297.49	408.84	628.33	942.84
Increase Decrease in Cost	2.95	14.47	-48.86	-33.77	-124.64
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	219.54	230.21	259.1	241.45	250.21
Miscellaneous Expenses	553.08	593.01	867.69	1273.69	261.01
Operating Profit	135.47	86.18	165.12	184.45	155.09
Other Income	12.84	14.76	26.1	34.8	34.82
Depreciation	20.13	16.95	16.26	14.94	20.69
Interest	1.09	0.95	0.63	1.2	0.99
Profit before tax and exceptio..	127.09	83.04	174.33	203.11	168.23
Exceptional Items	0	0	-40.23	16.43	-57.56
PBT	127.09	83.04	134.1	219.54	225.79
Provision for Taxation	33.79	21.44	34.81	58.03	28.71
Net Profit	93.3	61.6	99.29	161.51	81.92
NET Profit after MI	0	0	0	0	0
EPS	37.3	24.6	39.7	64.6	32.76
Operating Profit Margin (%)	16.65	10.7	16.46	14.24	10.45
Net Profit Margin (%)	11.47	7.65	9.9	12.47	5.52

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	75.00	75.00	75.00	75.00	75.00
FII	2.90	2.80	2.70	2.70	2.70
MF	5.00	5.00	3.80	2.80	2.40
Public	17.00	17.20	18.50	19.60	19.90
Others	0.00	0.00	0.00	0.00	0.00
Others	0.10	0.00	0.00	-0.10	0.00